NT
Nancy Thornberry (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $247K of DNLI (10,824 sh × $22.85, as filed), executed Sep 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$247K
shares × price, as filed
Last traded
Sep 2
Filed Sep 4
Median ADV $37.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $247K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
DNLI
Denali Therapeutics Inc.
DNLI · 0 buys · 1 sell
1 filing
Recent filings
DNLISALE
Denali Therapeutics Inc.
View filing →
$247K10,824 sh × $22.85
Exec Sep 2
Filed Sep 4 · 5:02 PM ET